ISRCTN45931429已完成1 期
Interleukin-1 receptor antagonist (IL-1RA) in subarachnoid haemorrhage (SAH) pharmacokinetic (PK) study 2
Salford Royal Foundation Hospital Trust (UK)0 个研究点目标入组 100 人开始时间: 2007年8月30日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Patients with confirmed spontaneous subarachnoid haemorrhage who require the placement of an external ventricular drain
- •2. No other health problems that in the opinion of the Investigator would interfere with participation, administration of study treatment or assessment of outcomes
- •3. No confirmed or suspected serious infection
- •4. Renal function within normal limits
- •5. Aged 16 or above
- •6. Willing and able to give consent to take part or consent available from the patient?s representative
- •7. Likely to remain within the study centre for the next 7 days
排除标准
- •1. Known allergy to E. coli or constituents of the investigational medicinal product
- •2. Previous or current treatment with Kineret® or anakinra
- •3. Previous participation in a clinical trial involving anakinra
- •4. Previous or current treatment potentially interacting with anakinra
- •5. Previous participants in other clinical intervention trials (within 30 days of last intervention)
- •6. Known to be pregnant or breastfeeding
研究者
相似试验
进行中（未招募）
2 期
The use of anakinra in treating complex regional pain syndrome by blocking interleukin-1Refractory complex regional pain syndromeNervous System DiseasesComplex regional pain syndromeISRCTN12908996niversity of Liverpool26
进行中（未招募）
不适用
Blocking the inflammation-factor IL-1 as treatment for degenerative joint disease of the handsosteoarthritis of the handEUCTR2012-004089-16-ATniversitätsklinik für Innere Medizin III, Klinische Abteilung für Rheumatologie, Medizinische Universität Wien
进行中（未招募）
1 期
Investigation of the effect of Interleukin-1 receptor antagonist (IL-1ra) on markers of inflammation in non-ST elevation acute coronary syndromes - MRC-ILA-HEART studyWe wish to investigate Acute coronary syndromes (ACS). These are caused by blockages in the main arteries that supply the heart as a result of a process called atherosclerosis. These blockages prevent blood flow down the artery and therefore prevent the heart muscle getting the blood and oxygen that it needs to survive and function. They account for 15% of all deaths in the UK and are associated with considerable long term consequences among survivors.MedDRA version: 8.1 Level: PT Classification code 10051592 Term: Acute coronary syndromeEUCTR2006-001767-31-GBniversity of Sheffield186
已完成
不适用
Effect of Interleukin-1 receptor antagonist on insulin sensitivity in obese, insulin resistant individualsmaturity-onset diabetestype 2 diabetes mellitus10018424NL-OMON33714niversitair Medisch Centrum Sint Radboud12
进行中（未招募）
1 期
Effect of Interleukin-1 receptor antagonist on insulin sensitivity in subjects with type 1 diabetes mellitus. - Effect of IL-1RA on insulin sensitivityMedDRA version: 12.1Level: LLTClassification code 10012601Term: Diabetes mellitusdiabetes mellitusEUCTR2010-023479-24-NLRadboud University Nijmegen Medical Centre16